Institutional Ownership
Atea Pharmaceuticals Inc
CUSIP 04683R106COMAVIRQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
123
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | Bml Investment Partners, L.P. | 13G | 9.9% | 7.81M | SEC |
| 2 | Dec 5, 2025 | Fmr LLC | 13G/A | 11.6% | 9.10M | SEC |
| 3 | Aug 6, 2025 | Fmr LLC | 13G/A | 6.7% | 5.72M | SEC |
| 4 | May 14, 2025 | Jpm Partners LLC | 13G/A | 11.0% | 8.88M | SEC |
| 5 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 7.1% | 6.08M | SEC |
| 6 | Apr 17, 2025 | Radoff Family Foundation | 13D/A | 4.0% | — | SEC |
| 7 | Mar 21, 2025 | Radoff Family Foundation | 13D/A | 3.6% | — | SEC |
| 8 | Mar 4, 2025 | Radoff Family Foundation | 13D | 3.3% | — | SEC |
| 9 | Feb 14, 2025 | Ecor1 Capital, LLC | 13G/A | 4.0% | — | SEC |
| 10 | Dec 16, 2024 | Bml Investment Partners, L.P. | 13D | 8.5% | — | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Atea Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 11.95M | $64.30M |
| 2 | Blackrock, Inc. | 8.44M | $45.38M |
| 3 | Bml Capital Management, LLC | 7.06M | $37.98M |
| 4 | Tang Capital Management LLC | 4.81M | $25.90M |
| 5 | Bain Capital Life Sciences Investors, LLC | 2.36M | $12.70M |
| 6 | Two Sigma Investments, LP | 1.86M | $10.03M |
| 7 | Geode Capital Management, LLC | 1.75M | $9.41M |
| 8 | State Street Corp | 1.69M | $9.12M |
| 9 | Dimensional Fund Advisors LP | 1.26M | $6.75M |
| 10 | Rosalind Advisors, Inc. | 1.17M | $6.30M |